Key result
Transapical transcatheter aortic valve implantation in 7 high-risk patients successfully increased aortic valve area from 0.7 to 1.5 cm2 and reduced mean transaortic gradient from 32 to 11 mmHg at 6 months.
Why the study?
Does transapical transcatheter aortic valve replacement improve echocardiographic parameters and survival in high-risk patients with symptomatic aortic valve stenosis?
Population
7 patients with symptomatic aortic valve stenosis, mean age 77 years, deemed non-surgical candidates for…
Design
Editorial
Follow-up
6 months
Authors
Loading...
Transapical transcatheter aortic valve implantation is a feasible and innovative less-invasive approach that improves valve hemodynamics in high-risk patients with severe aortic stenosis.
Does transapical transcatheter aortic valve replacement improve echocardiographic parameters and survival in high-risk patients with symptomatic aortic valve stenosis?
Transapical transcatheter aortic valve implantation is a feasible and innovative less-invasive approach that improves valve hemodynamics in high-risk patients with severe aortic stenosis.
Friedhelm Beyersdorf (2006) conducted an editorial in Symptomatic aortic valve stenosis (n=7). Transapical transcatheter aortic valve implantation was evaluated on Aortic valve area and mean transaortic gradient. Transapical transcatheter aortic valve implantation in 7 high-risk patients successfully increased aortic valve area from 0.7 to 1.5 cm2 and reduced mean transaortic gradient from 32 to 11 mmHg at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: